Chris Cleary - Colorado BioScience Association

Chris Cleary is Vice President of Corporate
Development for Medtronic. During 2014, Chris led
the corporate development efforts for Medtronic’s
$43B acquisition of Covidien as well for Medtronic’s
acquisition of both Sapiens and NGC, for $200MM
and $350MM respectively.
Prior to 2014, Chris was CEO for Alesia Capital
Services LLC, providing advisory and financial
analysis services to Fortune 500 companies including Medtronic, Ally,
Macquarie Capital, Everbank, Goldman Sachs and Genpact.
Chris worked at GE Capital from 1995 to 2011, leading M&A teams that closed
acquisitions worth $60 billion of financial assets across more than 200
transactions in the United States, Canada, Chile, France, United Kingdom,
Germany, Japan, Australia, Thailand and China.
Chris also led numerous dispositions while at GE Capital, including the sale of
GE Access to Avnet; the sale of HNS Banco to Rabobank; the sale of Cantrex
and Corbeil to Sears Canada; the sale of $1B+ IKON copier lease portfolio to
Bank of America; and the sale of GE Capital’s CLEC businesses to Eschelon
In 2009, Chris managed GE Capital Americas’ commercial wholesale finance
platform focused on Construction, Agriculture, Transportation and Industrial
markets, completing a complex integration from multiple GE Capital and
Citicapital platforms.
Chris graduated from The Colorado College with a degree in Biology. He
received the GE Capital Chairman’s Award for M&A excellence, and was a
member of the General Electric Business Development senior leadership